Promoter CpG island hypermethylation during breast cancer progression

So Yeon Park, Hyeong Ju Kwon, Hee Eun Lee, Han Suk Ryu, Sung Won Kim, Jee Hyun Kim, In Ah Kim, Namhee Jung, Nam Yun Cho, Gyeong Hoon Kang

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

This study was designed to evaluate the changes in promoter CpG islands hypermethylation during breast cancer progression from pre-invasive lesions [flat epithelial atypia (FEA), atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS)] to invasive ductal carcinoma (IDC). We performed MethyLight analysis for the methylation status of 57 promoter CpG island loci in 20 IDCs and their paired normal breast tissues. After selecting 15 CpG island loci showing breast cancer-specific DNA methylation, another set of normal breast tissue (n=10), ADH/FEA (n=30), DCIS (n=35), and IDC (n=30) of the breast were analyzed for these loci. We found six new methylation markers of breast cancer, namely DLEC1, GRIN2B, HOXA1, MT1G, SFRP4, and TMEFF2, in addition to APC, GSTP1, HOXA10, IGF2, RARB, RASSF1A, RUNX3, SCGB3A1 (HIN-1), and SFRP1. The number of methylated genes increased stepwise from normal breast to ADH/FEA and DCIS, while IDC did not differ from DCIS. Methylation levels and frequencies of APC, DLEC1, HOXA1, and RASSF1A promoter CpG islands were significantly higher in ADH/FEA than in normal breast tissue. GRIN2B, GSTP1, HOXA1, RARB, RUNX3, SFRP1, and TMEFF2 showed higher methylation levels and frequencies in DCIS than in ADH/FEA. DICS and IDC did not differ in the methylation levels or frequencies for most CpG island loci except SFRP1 and HOXA10. Our findings showed that promoter CpG island methylation changed significantly in pre-invasive lesions, and was similar in IDC and DCIS, suggesting that CpG island methylation of tumor-related genes is an early event in breast cancer progression.

Original languageEnglish
Pages (from-to)73-84
Number of pages12
JournalVirchows Archiv
Volume458
Issue number1
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

CpG Islands
Carcinoma, Intraductal, Noninfiltrating
Breast Neoplasms
Methylation
Ductal Carcinoma
Breast
DNA Methylation
Genes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Park, S. Y., Kwon, H. J., Lee, H. E., Ryu, H. S., Kim, S. W., Kim, J. H., ... Kang, G. H. (2011). Promoter CpG island hypermethylation during breast cancer progression. Virchows Archiv, 458(1), 73-84. https://doi.org/10.1007/s00428-010-1013-6
Park, So Yeon ; Kwon, Hyeong Ju ; Lee, Hee Eun ; Ryu, Han Suk ; Kim, Sung Won ; Kim, Jee Hyun ; Kim, In Ah ; Jung, Namhee ; Cho, Nam Yun ; Kang, Gyeong Hoon. / Promoter CpG island hypermethylation during breast cancer progression. In: Virchows Archiv. 2011 ; Vol. 458, No. 1. pp. 73-84.
@article{fd7fbb2cd819452ab642dd856f6b9d5d,
title = "Promoter CpG island hypermethylation during breast cancer progression",
abstract = "This study was designed to evaluate the changes in promoter CpG islands hypermethylation during breast cancer progression from pre-invasive lesions [flat epithelial atypia (FEA), atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS)] to invasive ductal carcinoma (IDC). We performed MethyLight analysis for the methylation status of 57 promoter CpG island loci in 20 IDCs and their paired normal breast tissues. After selecting 15 CpG island loci showing breast cancer-specific DNA methylation, another set of normal breast tissue (n=10), ADH/FEA (n=30), DCIS (n=35), and IDC (n=30) of the breast were analyzed for these loci. We found six new methylation markers of breast cancer, namely DLEC1, GRIN2B, HOXA1, MT1G, SFRP4, and TMEFF2, in addition to APC, GSTP1, HOXA10, IGF2, RARB, RASSF1A, RUNX3, SCGB3A1 (HIN-1), and SFRP1. The number of methylated genes increased stepwise from normal breast to ADH/FEA and DCIS, while IDC did not differ from DCIS. Methylation levels and frequencies of APC, DLEC1, HOXA1, and RASSF1A promoter CpG islands were significantly higher in ADH/FEA than in normal breast tissue. GRIN2B, GSTP1, HOXA1, RARB, RUNX3, SFRP1, and TMEFF2 showed higher methylation levels and frequencies in DCIS than in ADH/FEA. DICS and IDC did not differ in the methylation levels or frequencies for most CpG island loci except SFRP1 and HOXA10. Our findings showed that promoter CpG island methylation changed significantly in pre-invasive lesions, and was similar in IDC and DCIS, suggesting that CpG island methylation of tumor-related genes is an early event in breast cancer progression.",
author = "Park, {So Yeon} and Kwon, {Hyeong Ju} and Lee, {Hee Eun} and Ryu, {Han Suk} and Kim, {Sung Won} and Kim, {Jee Hyun} and Kim, {In Ah} and Namhee Jung and Cho, {Nam Yun} and Kang, {Gyeong Hoon}",
year = "2011",
month = "1",
day = "1",
doi = "10.1007/s00428-010-1013-6",
language = "English",
volume = "458",
pages = "73--84",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "1",

}

Park, SY, Kwon, HJ, Lee, HE, Ryu, HS, Kim, SW, Kim, JH, Kim, IA, Jung, N, Cho, NY & Kang, GH 2011, 'Promoter CpG island hypermethylation during breast cancer progression', Virchows Archiv, vol. 458, no. 1, pp. 73-84. https://doi.org/10.1007/s00428-010-1013-6

Promoter CpG island hypermethylation during breast cancer progression. / Park, So Yeon; Kwon, Hyeong Ju; Lee, Hee Eun; Ryu, Han Suk; Kim, Sung Won; Kim, Jee Hyun; Kim, In Ah; Jung, Namhee; Cho, Nam Yun; Kang, Gyeong Hoon.

In: Virchows Archiv, Vol. 458, No. 1, 01.01.2011, p. 73-84.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Promoter CpG island hypermethylation during breast cancer progression

AU - Park, So Yeon

AU - Kwon, Hyeong Ju

AU - Lee, Hee Eun

AU - Ryu, Han Suk

AU - Kim, Sung Won

AU - Kim, Jee Hyun

AU - Kim, In Ah

AU - Jung, Namhee

AU - Cho, Nam Yun

AU - Kang, Gyeong Hoon

PY - 2011/1/1

Y1 - 2011/1/1

N2 - This study was designed to evaluate the changes in promoter CpG islands hypermethylation during breast cancer progression from pre-invasive lesions [flat epithelial atypia (FEA), atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS)] to invasive ductal carcinoma (IDC). We performed MethyLight analysis for the methylation status of 57 promoter CpG island loci in 20 IDCs and their paired normal breast tissues. After selecting 15 CpG island loci showing breast cancer-specific DNA methylation, another set of normal breast tissue (n=10), ADH/FEA (n=30), DCIS (n=35), and IDC (n=30) of the breast were analyzed for these loci. We found six new methylation markers of breast cancer, namely DLEC1, GRIN2B, HOXA1, MT1G, SFRP4, and TMEFF2, in addition to APC, GSTP1, HOXA10, IGF2, RARB, RASSF1A, RUNX3, SCGB3A1 (HIN-1), and SFRP1. The number of methylated genes increased stepwise from normal breast to ADH/FEA and DCIS, while IDC did not differ from DCIS. Methylation levels and frequencies of APC, DLEC1, HOXA1, and RASSF1A promoter CpG islands were significantly higher in ADH/FEA than in normal breast tissue. GRIN2B, GSTP1, HOXA1, RARB, RUNX3, SFRP1, and TMEFF2 showed higher methylation levels and frequencies in DCIS than in ADH/FEA. DICS and IDC did not differ in the methylation levels or frequencies for most CpG island loci except SFRP1 and HOXA10. Our findings showed that promoter CpG island methylation changed significantly in pre-invasive lesions, and was similar in IDC and DCIS, suggesting that CpG island methylation of tumor-related genes is an early event in breast cancer progression.

AB - This study was designed to evaluate the changes in promoter CpG islands hypermethylation during breast cancer progression from pre-invasive lesions [flat epithelial atypia (FEA), atypical ductal hyperplasia (ADH), and ductal carcinoma in situ (DCIS)] to invasive ductal carcinoma (IDC). We performed MethyLight analysis for the methylation status of 57 promoter CpG island loci in 20 IDCs and their paired normal breast tissues. After selecting 15 CpG island loci showing breast cancer-specific DNA methylation, another set of normal breast tissue (n=10), ADH/FEA (n=30), DCIS (n=35), and IDC (n=30) of the breast were analyzed for these loci. We found six new methylation markers of breast cancer, namely DLEC1, GRIN2B, HOXA1, MT1G, SFRP4, and TMEFF2, in addition to APC, GSTP1, HOXA10, IGF2, RARB, RASSF1A, RUNX3, SCGB3A1 (HIN-1), and SFRP1. The number of methylated genes increased stepwise from normal breast to ADH/FEA and DCIS, while IDC did not differ from DCIS. Methylation levels and frequencies of APC, DLEC1, HOXA1, and RASSF1A promoter CpG islands were significantly higher in ADH/FEA than in normal breast tissue. GRIN2B, GSTP1, HOXA1, RARB, RUNX3, SFRP1, and TMEFF2 showed higher methylation levels and frequencies in DCIS than in ADH/FEA. DICS and IDC did not differ in the methylation levels or frequencies for most CpG island loci except SFRP1 and HOXA10. Our findings showed that promoter CpG island methylation changed significantly in pre-invasive lesions, and was similar in IDC and DCIS, suggesting that CpG island methylation of tumor-related genes is an early event in breast cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=78651313568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651313568&partnerID=8YFLogxK

U2 - 10.1007/s00428-010-1013-6

DO - 10.1007/s00428-010-1013-6

M3 - Article

C2 - 21120523

AN - SCOPUS:78651313568

VL - 458

SP - 73

EP - 84

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 1

ER -